Form 4: Cerus Corp Executive Richard J. Benjamin Acquires 160,000 Restricted Stock Units

Cerus Corporation's Chief Medical Officer, Richard J. Benjamin, acquired 160,000 Restricted Stock Units (RSUs) on March 1, 2024, according to a recent SEC filing.

Summary

• Richard J. Benjamin, Chief Medical Officer of Cerus Corporation, acquired 160,000 Restricted Stock Units (RSUs) on March 1, 2024.
• The RSUs were granted at a price of $0.00.
• Following the transaction, Benjamin directly owns 507,439 securities.
• The RSUs vest in two annual installments: 1/3 on March 12, 2025, and 2/3 on March 12, 2026, contingent upon continuous service to Cerus Corporation.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of RSUs to a key executive suggests confidence in the company's future, but it's a routine transaction.

Positives

• The acquisition of RSUs by a key executive signals confidence in the company's future performance.

Future Outlook

The vesting schedule of the RSUs (March 12, 2025, and March 12, 2026) incentivizes the Reporting Person's continuous service to the Issuer.

Industry Context

Executive compensation through stock grants is a common practice in the biotech industry to align management's interests with those of shareholders.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive sign, aligning executive interests with company performance.

Key Dates